Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia (Q37450852)

20 August 2017

Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia (English)

1 reference

20 August 2017

1 reference

human papillomavirus 16

1 reference

based on heuristic

inferred from title

human papilloma virus

1 reference

human papillomavirus

29 September 2024

Gina S Ogilvie

10

0 references

Mel Krajden

1

object named as

Mel Krajden

1 reference

20 August 2017

2

Karuna Karunakaran

1 reference

20 August 2017

11

Martin Petric

1 reference

20 August 2017

8

Ron Chow

1 reference

20 August 2017

Stacy So

3

1 reference

20 August 2017

Joel M Palefsky

4

1 reference

20 August 2017

Rachna Sharma

5

1 reference

20 August 2017

Darrel Cook

6

1 reference

20 August 2017

Amanda Yu

7

1 reference

20 August 2017

Simon Dobson

9

1 reference

20 August 2017

14 October 2009

1 reference

Clinical and Vaccine Immunology

20 August 2017

1 reference

20 August 2017

16

1 reference

20 August 2017

12

1 reference

20 August 2017

1840-1843

1 reference

Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assay

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroprevalence of 34 human papillomavirus types in the German general population

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Generation of HPV pseudovirions using transfection and their use in neutralization assays.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vacc

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroepidemiology as basis for design of a human papillomavirus vaccination program.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786386

Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19828766

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/CVI.00238-09

1 reference

release_7ialnskfbzg2toduvnv5yitjvu

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ialnskfbzg2toduvnv5yitjvu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

20 August 2017

PubMed publication ID

19828766

1 reference